Stephen Brand

751 total citations
23 papers, 565 citations indexed

About

Stephen Brand is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Stephen Brand has authored 23 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Microbiology. Recurrent topics in Stephen Brand's work include Antifungal resistance and susceptibility (10 papers), Reproductive tract infections research (7 papers) and Fungal Infections and Studies (6 papers). Stephen Brand is often cited by papers focused on Antifungal resistance and susceptibility (10 papers), Reproductive tract infections research (7 papers) and Fungal Infections and Studies (6 papers). Stephen Brand collaborates with scholars based in United States, United Kingdom and Canada. Stephen Brand's co-authors include Michael B. Mathews, Ryûji Kobayashi, Thorsten P. Degenhardt, Robert J. Schotzinger, Jack D. Sobel, Mahmoud A. Ghannoum, Paul Nyirjesy, Robert M. Bernstein, M B Mathews and Amir Tavakkol and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

Stephen Brand

22 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Brand United States 12 258 241 155 148 60 23 565
Virginia Takahashi United States 11 132 0.5× 185 0.8× 147 0.9× 162 1.1× 24 0.4× 15 503
Timothy J. Holzer United States 12 235 0.9× 366 1.5× 140 0.9× 251 1.7× 55 0.9× 23 716
E. Weigl Czechia 13 120 0.5× 151 0.6× 163 1.1× 114 0.8× 29 0.5× 32 504
Jérôme Nigou France 5 294 1.1× 280 1.2× 140 0.9× 305 2.1× 27 0.5× 6 602
Christophe J. Queval France 13 334 1.3× 386 1.6× 216 1.4× 157 1.1× 23 0.4× 19 736
Naoto Yoshino Japan 14 131 0.5× 146 0.6× 151 1.0× 288 1.9× 29 0.5× 42 619
Susanna Aprea Italy 11 70 0.3× 119 0.5× 182 1.2× 271 1.8× 90 1.5× 13 550
Gerd Lipowsky Latvia 8 92 0.4× 86 0.4× 171 1.1× 109 0.7× 42 0.7× 8 424
Jean–Marc Juteau United States 9 81 0.3× 205 0.9× 131 0.8× 39 0.3× 36 0.6× 14 428
Jake Whang South Korea 16 261 1.0× 340 1.4× 239 1.5× 143 1.0× 12 0.2× 38 628

Countries citing papers authored by Stephen Brand

Since Specialization
Citations

This map shows the geographic impact of Stephen Brand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Brand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Brand more than expected).

Fields of papers citing papers by Stephen Brand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Brand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Brand. The network helps show where Stephen Brand may publish in the future.

Co-authorship network of co-authors of Stephen Brand

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Brand. A scholar is included among the top collaborators of Stephen Brand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Brand. Stephen Brand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lederman, Samuel, et al.. (2025). Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis. Journal of Women s Health. 35(3). 334–339.
2.
Martens, Mark G., et al.. (2022). Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections. American Journal of Obstetrics and Gynecology. 227(6). 880.e1–880.e11. 44 indexed citations
3.
Sobel, Jack D., et al.. (2022). Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis. NEJM Evidence. 1(8). EVIDoa2100055–EVIDoa2100055. 27 indexed citations
4.
5.
Ghannoum, Mahmoud A., et al.. (2021). 719. Susceptibility Testing of Oteseconazole (VT-1161) Against Clinical Isolates from Phase 3 Clinical Studies in Subjects with Recurrent Vulvovaginal Candidiasis. Open Forum Infectious Diseases. 8(Supplement_1). S459–S459. 3 indexed citations
6.
7.
Brand, Stephen, Jack D. Sobel, Paul Nyirjesy, et al.. (2020). A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis. Clinical Infectious Diseases. 73(7). e1518–e1524. 45 indexed citations
8.
Brand, Stephen, Thorsten P. Degenhardt, Jack D. Sobel, et al.. (2018). A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis. American Journal of Obstetrics and Gynecology. 218(6). 624.e1–624.e9. 59 indexed citations
9.
Sobel, Jack D., Stephen Brand, Thorsten P. Degenhardt, et al.. (2017). Results from a phase 2, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of VT 1161 oral tablets in the treatment of patients with recurrent vulvovaginal candidiasis. American Journal of Obstetrics and Gynecology. 217(6). 715–715. 5 indexed citations
10.
Brand, Stephen, Thorsten P. Degenhardt, Paul Nyirjesy, et al.. (2016). 15: To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC). American Journal of Obstetrics and Gynecology. 215(6). S821–S821. 3 indexed citations
11.
Brand, Stephen, et al.. (2015). 17: Efficacy and safety of oral VT-11611 in a randomized phase 2a study in patients with acute vulvovaginal candidiasis: six-month follow-up. American Journal of Obstetrics and Gynecology. 213(6). 890–890. 1 indexed citations
12.
Narayanan, Niju, Stephen Brand, Charles A. Nicolette, et al.. (2010). Structural identification of recombinant human CD83 mutant variant as a potent therapeutic protein. Protein Expression and Purification. 73(2). 140–146. 5 indexed citations
13.
Ge, Wei, Jacqueline Arp, Dameng Lian, et al.. (2010). Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection. Transplantation. 90(11). 1145–1156. 55 indexed citations
14.
Lian, Dameng, Weihua Liu, Jacqueline Arp, et al.. (2010). Prevention of Chronic Renal Allograft Rejection by Soluble CD83. Transplantation. 90(12). 1278–1285. 37 indexed citations
15.
Xu, Yali, et al.. (2008). Bioprocess development for production, purification, and structural characterization of recombinant hCD83ext as a potential therapeutic protein. Protein Expression and Purification. 65(1). 92–99. 11 indexed citations
16.
Dambacher, Julia, Julia Seiderer, Fabian Schnitzler, et al.. (2006). The macrophage migration inhibitory factor (MIF) –173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease. Zeitschrift für Gastroenterologie. 44(10). 3 indexed citations
17.
Brand, Stephen, Ryûji Kobayashi, & Michael B. Mathews. (1997). The Tat Protein of Human Immunodeficiency Virus Type 1 Is a Substrate and Inhibitor of the Interferon-induced, Virally Activated Protein Kinase, PKR. Journal of Biological Chemistry. 272(13). 8388–8395. 127 indexed citations
18.
Brand, Stephen, Robert M. Bernstein, & M B Mathews. (1994). Autoreactive epitope profiles of the proliferating cell nuclear antigen define two classes of autoantibodies.. The Journal of Immunology. 152(8). 4120–4128. 14 indexed citations
19.
Brand, Stephen, Robert M. Bernstein, & M B Mathews. (1994). Trimeric structure of human proliferating cell nuclear antigen. Implications for enzymatic function and autoantibody recognition.. The Journal of Immunology. 153(7). 3070–3078. 24 indexed citations
20.
Brand, Stephen, Jane Worthington, Deirdre P. McIntosh, & Robert M. Bernstein. (1992). Antibody to a 63 kilodalton insect protein in ankylosing spondylitis.. Annals of the Rheumatic Diseases. 51(3). 334–339. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Takahashi Breakdown of academic impact, for papers by Timothy J. Holzer Breakdown of academic impact, for papers by E. Weigl Breakdown of academic impact, for papers by Jérôme Nigou Breakdown of academic impact, for papers by Christophe J. Queval Breakdown of academic impact, for papers by Naoto Yoshino Breakdown of academic impact, for papers by Susanna Aprea Breakdown of academic impact, for papers by Gerd Lipowsky Breakdown of academic impact, for papers by Jean–Marc Juteau Breakdown of academic impact, for papers by Jake Whang
Rankless by CCL
2026